Cite
HARVARD Citation
Antovic, A. et al. (2014). SAT0004 Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor - TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome. Annals of the rheumatic diseases. p. 591. [Online].